Phase 2 Sickle Cell Disease Trial, Recruiting NCT07369024 Sponsor: Mohsen Saidinejad Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Phase 2 Sickle Cell Disease Trial, Recruiting

NCT07369024
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 5 and 20 years old
  • You have been diagnosed with sickle cell disease (any of the following types: HbSS, HbSC, HbSBeta Thal Plus, or HbSBeta Thal Zero)
  • You are currently having a pain crisis related to sickle cell disease and need pain medicine given through an IV
  • You have already received your first dose of pain medicine before being asked to join the study
  • Your primary language is English or Spanish
  • If you are an adult, you are willing and able to give your own consent to participate; if you are a child, a parent or legal guardian can give consent, and children aged 7–17 will also be asked for their own agreement to participate when they are able to understand

Who may not be able to join:

  • You only have sickle cell trait (not the full disease)
  • Your main language is not English or Spanish
  • Your pain is caused by something other than a sickle cell pain crisis
  • You do not need IV pain medication for your current pain
  • You have not yet received any pain medicine before being approached for the study, for any reason (including difficulty placing an IV)
  • The level of oxygen in your blood is below 90% while breathing regular room air
  • You have had a bad reaction to the medicine ketamine in the past
  • You have high blood pressure that is not well controlled (blood pressure at or above 140/90 at the time of enrollment)
  • You have a significant or uncontrolled heart condition, liver disease, kidney disease, or thyroid disease
  • There are signs of increased pressure in your brain
  • You have increased pressure in your eyes
  • You have active mania, bipolar disorder with manic episodes, or a history of hallucinations or paranoia related to a previously diagnosed mental health condition
  • You are pregnant or may be pregnant (a pregnancy test will be done as part of your clinical care before enrollment, and a positive result will mean you cannot join)
  • Your liver enzyme blood test results (if available before the study) show signs that your liver is not working properly
  • You appear to be under the influence of alcohol or any other substance at the time of the study
  • You are a ward of the state or a prisoner as defined by the Department of Human Services
  • You or your guardian are not considered able to fully understand and agree to participation in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 310-222-2345

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Mohsen Saidinejad
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total Opioid Medications Required for Analgesia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov